TORONTO, March 15, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSX-V: FTHW) ("Field Trip" or the "Company") today announced that, in an effort to reduce expenditures and preserve capital, it will be closing the Field Trip Health Centres located in Chicago, Washington DC, Seattle, San Diego and Fredericton. The anticipated last day of operation for each of these locations will be on or around April 15, 2023.
Clients in each of these locations will be receiving notice of clinic closures which will include, among other things, information on finding alternative care providers, how to access their medical records and other information required by applicable laws and regulations.
The Independent Committee (the "IC") of the board of directors of the Company that was formed in December 2022 to assess strategic options for the Company, along with the IC's financial and legal advisors, continue to review the Company's operations and investigate alternate courses of actions including, but not limited to, further cost reductions, restructuring, the potential sublease or closure of clinic locations and settlement of lease obligations (the "Strategic Review"). The Company does not intend to comment further on the Strategic Review, unless and until the Board has approved a specific course of action or otherwise determined that further disclosure is appropriate or required by law.
About Field Trip Health & Wellness Ltd.
With a large global community of psychedelic-interested people, proprietary psychedelic therapies that generate transformative results for people in the treatment of mental health conditions and a brand and share of voice that is reaching millions of people, Field Trip is a center of gravity for the psychedelic renaissance.
Learn more at and
Follow us on Twitter and Instagram: @fieldtriphealth
To receive company updates about Field Trip and to be added to the email distribution list please sign up here.
Cautionary Note Regarding Forward-Looking Information
This release includes forward-looking information (within the meaning of Canadian securities laws and within the meaning of the United States Private Securities Litigation Reform Act of 1995) regarding the Company and its business. Often but not always, forward-looking information can be identified by the use of words such as "expect", "intends", "anticipated", "believes" or variations (including negative variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would" or "will" be taken, occur or be achieved. Such statements are based on the current expectations and views of future events of the management of the Company and are based on assumptions and subject to risks and uncertainties. Although the management believes that the assumptions underlying these statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the companies. Although the Company has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. Accordingly, readers should not place undue reliance on any forward-looking statements or information. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and the Company does not undertake any obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. Additional information relating to the Company, can be located on the SEDAR website at .
Neither the TSX Venture Exchange, nor its Regulation Services Provider, have approved the contents of this release or accept responsibility for the adequacy or accuracy of this release.
CONTACTS:
Field Trip Health & Wellness:
Ronan Levy
Chairman & CEO
(416) 505-0929
ronan@fieldtriphealth.com
Investor contacts:
Phil Carlson / Sophia Bashford
KCSA Strategic Communications
(646) 573-0776) / (929 246-7307)
fieldtripIR@kcsa.com
Media contacts:
Isabella Morreale
Autumn Communications
(862) 579-7944
press@fieldtriphealth.com
SOURCE Field Trip Health & Wellness Ltd.
多倫多，2023年3月15日(環球通訊社)--實地考察健康與健康有限公司(多倫多證券交易所股票代碼：FTHW)(以下簡稱“實地考察”或“公司”)今天宣佈，為了減少開支和節約資本，將關閉位於芝加哥、華盛頓特區、西雅圖、聖地亞哥和弗雷德裡克頓的實地考察衛生中心。預計這些地點的最後一天將於2023年4月15日或前後投入運營。
這些地點的客戶將收到診所關閉的通知，其中除其他外，將包括尋找替代護理提供者的資訊、如何獲取他們的醫療記錄以及適用法律和法規要求的其他資訊。
本公司董事會獨立委員會於2022年12月成立，以評估本公司的策略選擇，連同獨立委員會的財務及法律顧問，繼續檢討本公司的營運及研究其他行動方案，包括但不限於進一步削減成本、重組、可能轉租或關閉診所地點及清償租賃責任(“策略檢討”)。本公司不打算就策略檢討作出進一步評論，除非及直至董事會已批准一項具體行動方案或以其他方式決定進一步披露是適當的或法律規定的。
關於野外旅行健康與健康有限公司。
擁有一個龐大的全球迷幻人群社區，專有的迷幻療法可以為人們的心理健康治療帶來革命性的結果，而且有一個品牌和分享的聲音正在接觸到數百萬人，菲爾德旅行是迷幻復興的重心。
瞭解更多資訊，請訪問和
在推特和Instagram上關注我們：@fieldtriphealth
要接收有關實地考察旅行的公司更新並將其添加到電子郵件分發列表中，請在此處註冊。
關於前瞻性資訊的注意事項
本新聞稿包括有關該公司及其業務的前瞻性資訊(符合加拿大證券法和1995年美國私人證券訴訟改革法的定義)。前瞻性資訊往往但不總是可以通過使用諸如“預期”、“打算”、“預期”、“相信”或這些詞語和短語的變體(包括負面變體)來確定，或者聲明某些行動、事件或結果“可能”、“可能”、“將”或“將”被採取、發生或實現。這些陳述是基於公司管理層對未來事件的當前預期和看法，是基於假設的，受風險和不確定因素的影響。儘管管理層認為這些陳述所依據的假設是合理的，但它們可能被證明是不正確的。本新聞稿中討論的前瞻性事件和情況可能不會發生，可能會因影響這些公司的已知和未知風險因素和不確定性而大不相同。儘管公司試圖確定可能導致實際行動、事件或結果與前瞻性陳述中描述的大不相同的重要因素，但可能還有其他因素導致行動、事件或結果與預期、估計或預期的不同。因此，讀者不應過分依賴任何前瞻性陳述或資訊。任何前瞻性陳述都不能得到保證。除適用的證券法要求外，前瞻性表述僅在作出之日發表，公司不承擔任何公開更新或修改任何前瞻性表述的義務，無論是由於新資訊、未來事件或其他原因。有關公司的更多資訊，可在SEDAR網站上找到。
多倫多證券交易所創業板交易所及其監管服務提供商均未批准本新聞稿的內容，也未對本新聞稿的充分性或準確性承擔責任。
聯繫人：
實地考察健康與健康：
羅南·利維
董事長兼首席執行官
(416)505-0929
郵箱：ronan@fieldtriphelth.com
投資者聯繫方式：
菲爾·卡爾森/索菲亞·巴什福德
KCSA戰略傳播
(646)573-0776)/(929 246-7307)
郵箱：fieldtripIR@kcsa.com
媒體聯繫人：
伊莎貝拉·莫裡亞爾
秋季通信
(862)579-7944
按下@fieldtriphelth.com
來源：野外旅行健康健康有限公司。
